✦ LIBER ✦

PMH35 COST-EFFECTIVENESS OF MEMANTINE IN THE TREATMENT OF MODERATE AND SEVERE ALZHEIMER'S DISEASE PATIENTS WITH AGITATION, AGGRESSION AND PSYCHOSIS—THE UK EXAMPLE

✍ Scribed by Rive, B; Grishchenko, M; Guilhaume, C; Katona, C; Lamure, M; Livingston, G; Toumi, M; Francois, C

Book ID: 122188848
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 77 KB
Volume: 13
Category: Article
ISSN: 1098-3015
DOI: 10.1016/S1098-3015(11)72912-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PND25 COST-EFFECTIVENESS OF MEMANTINE IN

PND25 COST-EFFECTIVENESS OF MEMANTINE IN THE TREATMENT OF MODERATE TO SEVERE ALZHEIMER'S DISEASE IN NORWAY

✍ M Toumi; M Lamure; M Grishchenko; J Cochran; B Rive 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

PNM10 COST EFFECTIVENESS OF MEMANTINE IN

PNM10 COST EFFECTIVENESS OF MEMANTINE IN THE TREATMENT OF MODERATELY SEVERE AND SEVERE ALZHEIMER'S DISEASE IN SPAIN

✍ F Antonanzas; J Badenas; C François; C Guilhaume 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

A Systematic Review of the Clinical and

A Systematic Review of the Clinical and Cost-Effectiveness of Memantine in Patients with Moderately Severe to Severe Alzheimer’s Disease

✍ Joanna Kirby, Mr Colin Green, Emma Loveman, Andrew Clegg, Joanna Picot… 📂 Article 📅 2006 🏛 Springer International Publishing AG 🌐 English ⚖ 155 KB

A Markov Model of the Cost Effectiveness

A Markov Model of the Cost Effectiveness of Olanzapine Treatment for Agitation and Psychosis in Alzheimer’s Disease

✍ Stephanie Kirbach, Kit Simpson, Paul J. Nietert, Jacobo Mintzer 📂 Article 📅 2008 🏛 Springer International Publishing AG 🌐 English ⚖ 129 KB

Updated cost-effectiveness projections f

Updated cost-effectiveness projections for donepezil in the treatment of patients with mild-to-moderately severe Alzheimer's disease in the UK

✍ Maclaine, Grant; Getsios, Denis; Blume, Steve; Ishak, Jack 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Tolerability of switching from donepezil

Tolerability of switching from donepezil to memantine treatment in patients with moderate to severe Alzheimer's disease

✍ Gunhild Waldemar; Maritta Hyvärinen; Mette Krog Josiassen; Alex Kørner; Heikki L 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 44 KB 👁 2 views

This study investigates the tolerability, safety and efficacy of abrupt or stepwise switching from donepezil to memantine treatment in patients with moderate-to-severe Alzheimer's disease (AD). Outpatients (Table 1), !50 years, with dementia of the Alzheimer's type (DSM-IV-TR), MMSE 18 and receiving